IBDEI25S ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,36200,1,3,0)
 ;;=3^Acute salpingitis
 ;;^UTILITY(U,$J,358.3,36200,1,4,0)
 ;;=4^N70.01
 ;;^UTILITY(U,$J,358.3,36200,2)
 ;;=^5015802
 ;;^UTILITY(U,$J,358.3,36201,0)
 ;;=N70.02^^166^1835^11
 ;;^UTILITY(U,$J,358.3,36201,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36201,1,3,0)
 ;;=3^Acute oophoritis
 ;;^UTILITY(U,$J,358.3,36201,1,4,0)
 ;;=4^N70.02
 ;;^UTILITY(U,$J,358.3,36201,2)
 ;;=^5015803
 ;;^UTILITY(U,$J,358.3,36202,0)
 ;;=N70.03^^166^1835^13
 ;;^UTILITY(U,$J,358.3,36202,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36202,1,3,0)
 ;;=3^Acute salpingitis and oophoritis
 ;;^UTILITY(U,$J,358.3,36202,1,4,0)
 ;;=4^N70.03
 ;;^UTILITY(U,$J,358.3,36202,2)
 ;;=^270465
 ;;^UTILITY(U,$J,358.3,36203,0)
 ;;=N70.11^^166^1835^30
 ;;^UTILITY(U,$J,358.3,36203,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36203,1,3,0)
 ;;=3^Chronic salpingitis
 ;;^UTILITY(U,$J,358.3,36203,1,4,0)
 ;;=4^N70.11
 ;;^UTILITY(U,$J,358.3,36203,2)
 ;;=^5015804
 ;;^UTILITY(U,$J,358.3,36204,0)
 ;;=N70.12^^166^1835^29
 ;;^UTILITY(U,$J,358.3,36204,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36204,1,3,0)
 ;;=3^Chronic oophoritis
 ;;^UTILITY(U,$J,358.3,36204,1,4,0)
 ;;=4^N70.12
 ;;^UTILITY(U,$J,358.3,36204,2)
 ;;=^5015805
 ;;^UTILITY(U,$J,358.3,36205,0)
 ;;=N70.13^^166^1835^31
 ;;^UTILITY(U,$J,358.3,36205,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36205,1,3,0)
 ;;=3^Chronic salpingitis and oophoritis
 ;;^UTILITY(U,$J,358.3,36205,1,4,0)
 ;;=4^N70.13
 ;;^UTILITY(U,$J,358.3,36205,2)
 ;;=^270466
 ;;^UTILITY(U,$J,358.3,36206,0)
 ;;=N73.9^^166^1835^53
 ;;^UTILITY(U,$J,358.3,36206,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36206,1,3,0)
 ;;=3^Female pelvic inflammatory disease, unspecified
 ;;^UTILITY(U,$J,358.3,36206,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,36206,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,36207,0)
 ;;=N72.^^166^1835^59
 ;;^UTILITY(U,$J,358.3,36207,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36207,1,3,0)
 ;;=3^Inflammatory disease of cervix uteri
 ;;^UTILITY(U,$J,358.3,36207,1,4,0)
 ;;=4^N72.
 ;;^UTILITY(U,$J,358.3,36207,2)
 ;;=^5015812
 ;;^UTILITY(U,$J,358.3,36208,0)
 ;;=N76.0^^166^1835^14
 ;;^UTILITY(U,$J,358.3,36208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36208,1,3,0)
 ;;=3^Acute vaginitis
 ;;^UTILITY(U,$J,358.3,36208,1,4,0)
 ;;=4^N76.0
 ;;^UTILITY(U,$J,358.3,36208,2)
 ;;=^5015826
 ;;^UTILITY(U,$J,358.3,36209,0)
 ;;=N76.1^^166^1835^95
 ;;^UTILITY(U,$J,358.3,36209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36209,1,3,0)
 ;;=3^Subacute and chronic vaginitis
 ;;^UTILITY(U,$J,358.3,36209,1,4,0)
 ;;=4^N76.1
 ;;^UTILITY(U,$J,358.3,36209,2)
 ;;=^5015827
 ;;^UTILITY(U,$J,358.3,36210,0)
 ;;=N75.0^^166^1835^34
 ;;^UTILITY(U,$J,358.3,36210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36210,1,3,0)
 ;;=3^Cyst of Bartholin's gland
 ;;^UTILITY(U,$J,358.3,36210,1,4,0)
 ;;=4^N75.0
 ;;^UTILITY(U,$J,358.3,36210,2)
 ;;=^5015822
 ;;^UTILITY(U,$J,358.3,36211,0)
 ;;=N75.1^^166^1835^5
 ;;^UTILITY(U,$J,358.3,36211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36211,1,3,0)
 ;;=3^Abscess of Bartholin's gland
 ;;^UTILITY(U,$J,358.3,36211,1,4,0)
 ;;=4^N75.1
 ;;^UTILITY(U,$J,358.3,36211,2)
 ;;=^5015823
 ;;^UTILITY(U,$J,358.3,36212,0)
 ;;=N76.4^^166^1835^6
 ;;^UTILITY(U,$J,358.3,36212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36212,1,3,0)
 ;;=3^Abscess of vulva
 ;;^UTILITY(U,$J,358.3,36212,1,4,0)
 ;;=4^N76.4
 ;;^UTILITY(U,$J,358.3,36212,2)
 ;;=^5015830
 ;;^UTILITY(U,$J,358.3,36213,0)
 ;;=N80.0^^166^1835^46
 ;;^UTILITY(U,$J,358.3,36213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,36213,1,3,0)
 ;;=3^Endometriosis of uterus
 ;;^UTILITY(U,$J,358.3,36213,1,4,0)
 ;;=4^N80.0
